Clinical Trial

A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will evaluate the efficacy and safety of 608 in patients with nr-axSpA.
Trial Details
NCT Number NCT07349329
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Axial Spondyloarthritis, Non-Radiographic
Enrollment 380 participants
Start Date 2026-03-09
Primary Completion 2028-04-19 (estimated)
Study Completion 2029-02-21 (estimated)
Updated on ClinicalTrials.gov 2026-01-16